|
Pfizer cuts forecasts as generics threats become reality - Pharma Times (subscription)Pfizer cuts forecasts as generics threats become realityPharma Times (subscription), UK - Apr 23, 2007The erectile dysfunction drug Viagra (sildenafil) contributed $434 million (+11%), but the most pleasing performance came from Pfizer's new epilepsy and ... read more... |